The study by Guo et al. illuminated a possible therapeutic option by demonstrating how inhibiting Glo1 could prevent the growth of breast cancer by downregulating MMP-9 and Bcl-2 and altering the MAPK signaling pathway [95]. The gene discussed is GLO1; the disease is breast carcinoma.